With shares of Pfizer (NYSE:PFE) trading around $32, is PFE an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:
T = Trends for a Stock’s MovementPfizer�� rival Novartis is racing the former to develop a promising new type of breast cancer drug, which analysts believe could bring billions of dollars in yearly sales. The Swiss drug maker, which has prior to this kept its research program undercover, revealed Friday that its experimental pill LEE011 is primed to enter final-stage Phase III clinical trials in December. Pfizer�� rival drug palbociclib is already in Phase III testing, but Novartis��rapid progress means the group could face competition rather sooner than anticipated. Both drugs are pills, and work by blocking two enzymes called cyclin dependent kinases 4 and 6.
Pfizer�� rival Novartis is racing the former to develop a promising new type of breast cancer drug, which analysts believe could bring billions of dollars in yearly sales. The Swiss drug maker, which has prior to this kept its research program undercover, revealed Friday that its experimental pill LEE011 is primed to enter final-stage Phase III clinical trials in December. Pfizer�� rival drug palbociclib is already in Phase III testing, but Novartis��rapid progress means the group could face competition rather sooner than anticipated. Both drugs are pills, and work by blocking two enzymes called cyclin dependent kinases 4 and 6.
Hot Promising Companies To Invest In 2015: Gilead Sciences Inc.(GILD)
Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. Its products include Atripla, Truvada, Viread, Emtriva for the treatment of human immunodeficiency virus infection in adults; Hepsera, an oral formulation for the treatment of chronic hepatitis B; AmBisome, a amphotericin B liposome injection to treat invasive fungal infections; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa for the treatment of chronic angina; Vistide, an antiviral medication for the treatment of cytomegalovirus retinitis in patients with AIDS; and Cayston, an inhaled antibiotic used as a treatment to enhance respiratory systems. The company?s products also comprise Tamiflu, an oral antiviral for the treatment and prevention of influenza A and B; Macugen, an intravitreal injection for the treatment of neovascular a ge-related macular degeneration; and Lexiscan/Rapiscan, an injection used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging. Its products under the Phase III clinical trials consist of Cobicistat, a pharmacoenhancer that is under evaluation as a boosting agent for HIV medicines; Elvitegravir, an oral integrase inhibitor being evaluated as part of combination therapy for HIV; Integrase Single-Tablet, a ?Quad? regimen of elvitegravir, cobicistat, tenofovir disoproxil fumarate, and emtricitabine for the treatment of HIV/AIDS in treatment-naive patients; and Aztreonam for inhalation solution for the treatment of cystic fibrosis patients with Pseudomonas aeruginosa. The company?s Phase II clinical trials products comprise Cicletanine, Ranolazine, and Aztreonam, as well as GS 9190, GS 9256, and GS 9451. Its Phase I clinical trial products include GS 7340, GS 5885, GS 6620, GS 9620, and GS 6624. The company was founded in 1987 and is headquartered in Fost er City, California.
Advisors' Opinion:- [By Maxx Chatsko]
In the following video, Fool contributor Maxx Chatsko explains whether he thinks Gilead Sciences (NASDAQ: GILD ) or Amgen (NASDAQ: AMGN ) is the better buy. Both companies are trading at nearly identical market caps and have risen dramatically since the beginning of 2012 in anticipation of new blockbuster products. Both have robust pipelines stuffed full of potential at all levels of development. This is going to be a tough decision. If these companies are on your watchlist or if you're simply looking to add to a position, then you may want to use the current market volatility to your advantage.
- [By Myra P. Saefong]
Gilead Sciences (GILD) �reported late Tuesday that non-GAAP first-quarter net income, which excludes acquisition expenses and other one-off items, was $1.48 a share and said revenue reached $5 billion. The research-based biopharmaceutical company was expected to post quarterly earnings of 92 cents a share on revenue of $3.96 billion, according to FactSet consensus estimates.
Hot Promising Companies To Invest In 2015: Celsius Holdings Inc (CELH)
Celsius Holdings, Inc., incorporated on April 26, 2005, is engaged in the development, marketing, sale and distribution of functional calorie-burning beverages under the Celsius brand name. The Company focuses to combine nutritional science with mainstream beverages by using its thermogenic (calorie-burning) MetaPlus formulation. The Company does not directly manufacture its beverages, but instead outsource the manufacturing process to established third-party co-packers. The Company provides its co-packers with flavors, ingredient blends, cans and other raw materials for its beverages purchased by the Company from various suppliers. Celsius, Inc. and Elite FX, Inc. are the wholly owned subsidiaries of the Company.
The Company�� Celsius is a calorie-burning beverage. Celsius is available in seven flavors, lemon-lime, ginger ale, cola, orange and wild berry (which are carbonated) and non-carbonated green tea raspberry/acai and green tea/peach mango. Its beverages are sold in 12 ounce cans, although it has begun to market the ingredients in powdered form in individual On-The-Go packets. The Company�� customer�� include on-the-go women, age 25 to 54, who are looking for a way to burn calories and gain energy with beverages and natural alternatives to diet sodas, as well as sports enthusiasts of both sexes, who are seeking low sodium, preservative-free alternatives. During the year ended December 31, 2009, the Company developed its MetaPlus formulation into a powder that can be mixed with water.
The Company competes with The Coca-Cola Company, Dr. Pepper Snapple Group, PepsiCo, Inc., Nestl茅, Waters North America, Inc., Hansen Natural Corp., and Red Bull.
Advisors' Opinion:- [By John Udovich]
Monster Beverage Corp (NASDAQ: MNST), a mid cap marketer and distributor of energy drinks and alternative beverages, has been a monster of a performer since the end of the financial crisis as the stock is up around 308% over the past five years, but could new or overlooked players like small cap beverage stocks�Jones Soda Co (OTCMKTS: JSDA), Celsius Holdings, Inc (OTCMKTS: CELH) and Konared Corp (OTCBB: KRED) repeat that performance? A look strictly at the long term performance of all three small caps might have you thinking otherwise. After all, none of these small cap beverage stocks are profitable while�the beverage industry can be a long hard expensive slog just to increase market share by one or two points when you are competing for shelf space with industry giants like Pepsi and Coke. But past performance is just that���the past and only part of the story as there is much more to consider about these small cap beverage stocks which could also make them potential acquisition targets by larger beverage players seeking to expand their product line up with innovative products:
Top New Companies To Watch In Right Now: 51job Inc.(JOBS)
51job, Inc. provides integrated human resource services primarily in the People?s Republic of China. . The company provides recruitment related advertising services, including print advertising services through 51job Weekly, which is a city-specific recruitment advertising publication that is published once a week and is distributed as an insert in local newspapers and/or on a stand-alone basis; and online recruitment services through its Website, www.51job.com. It also offers other human resource related services, such as business process outsourcing, which consist of social insurance and welfare payment processing, regulatory compliance, and payroll processing; and executive search services, as well as conducts training seminars in the areas of business management, leadership, sales and marketing, human resource, negotiation skills, financial planning and analysis, public administration, manufacturing, secretarial, and other skills for the general public and corporate cl ients. In addition, the company provides campus recruitment services; conducts salary, employee retention, and other human resource related surveys; organize and host annual human resource conferences and events, which include lectures, seminars, workshops, and networking opportunities for human resource professionals; and provides assessment tools to assist human resource departments in evaluating capabilities and dispositions of job candidates and existing employees, aiding employee placement, and allocating employee resources, as well as hiring and support services to employers on select recruitment projects. It provides recruitment and other human resource related services to employers through its sales offices, as well as through its sales and customer service call center. The company was founded in 1998 and is based in Shanghai, the People?s Republic of China.
Advisors' Opinion:- [By Ben Rooney]
51job (JOBS), an online job search website similar to Monster.com (MWW), has surged more 60% this year.
But there is one notable Chinese dot-com stock that's sitting out the big rally. Shares of Renren (RENN), the social network known as China's Facebook (FB, Fortune 500), are down 3% for the year.
Hot Promising Companies To Invest In 2015: Sappi Limited(SPP)
Sappi Limited manufactures and sells various pulp, paper, chemical cellulose, and wood products worldwide. It offers coated woodfree paper used for marketing promotions and brochures, catalogues, corporate communications materials, direct mail, textbooks, and magazines; uncoated woodfree paper used for business forms, business stationery, tissue, photocopy paper, books, brochures, and magazines, as well as cut-size, preprint, and office paper; specialty woodfree paper used in bags, labels, and packaging; and release paper for use in textile, automotive, furniture, and engineering film markets. The company also provides packaging paper products, including containerboards, sack kraft, and grocery bags used for primary and secondary packaging of fast moving consumer goods, and agricultural and industrial products. In addition, it offers mechanical newsprint paper used in advertising inserts and newspapers; uncoated mechanical fiber based printing paper used for the printing o f books and advertising inserts; and coated mechanical fiber-based paper used for magazines, catalogues, and advertising material. Further, the company provides pulp products, including paper pulp used in the production of printing, writing, and packaging paper; and chemical cellulose used in the manufacture of various cellulose textile and non-woven fiber products, as well as used in various other cellulose-based applications in the food, film, cigarette, chemical, and pharmaceutical industries. Additionally, Sappi Limited offers sawn timber for construction and furniture manufacturing purposes. Its customers include printers, publishers, corporate end-users, suppliers, and converters. The company was formerly known as South African Pulp and Paper Industries Limited and changed its name to Sappi Limited in 1973. Sappi Limited was founded in 1936 and is headquartered in Johannesburg, South Africa.
Advisors' Opinion:- [By Seth Jayson]
Sappi (NYSE: SPP ) reported earnings on May 9. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q2), Sappi beat slightly on revenues and met expectations on earnings per share.
Hot Promising Companies To Invest In 2015: King George Financial Corp (KGF)
King George Financial Corporation is a Canada-based company. The Company operates in the area of commercial and residential real estate investment holding and development, as well as medium to long term investment in real estate and hotel related marketable securities. The Company has four segments: rental operation, real estate development, management and finance services, and others. Its principle assets include an office building in downtown Vancouver, British Columbia, held through its 100% subsidiary 905 W. Pender Investments Ltd; real estate located in the City of Surrey, British Columbia, held through its subsidiary 0819277 BC Ltd, 0788607 BC Ltd, and 50% ownership interest in Surrey Campus Residences Joint Venture. The real estate assets consist of residential building lots, and investment in common shares of Allied Hotel Properties Inc., a hotel ownership and management company, and United Malayan Land BHD (UML), a Malaysian real estate development company. Advisors' Opinion:- [By Sofia Horta e Costa]
Kingfisher Plc (KGF) declined 5.7 percent to 373.6 pence, its biggest loss in more than two years, after Chief Executive Officer Ian Cheshire said consumer confidence in France ��s still weak with no obvious signs of an imminent improvement.�� Europe�� largest home-improvement retailer also reported same-store sales growth of 0.4 percent for its B&Q chain in the U.K. and Ireland, missing analysts��estimates. France accounted for about 40 percent of its sales and the U.K. for 41 percent, data compiled by Bloomberg showed.
No comments:
Post a Comment